Abstract Tumor necrosis component-associated apoptosis-inducing ligand (TRAIL) is a cytotoxic cytokine that induces cancer cell Demise by binding to TRAIL receptors. Thanks to its selective cytotoxicity toward cancer cells, Path therapeutics, such as recombinant TRAIL and agonistic antibodies focusing on Path receptors, have garnered interest as promising most cancers therapy https://betteq539eil2.wikitron.com/user